Researchers from Massachusetts General Brigham and colleagues found that the use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023, and surgery...
New research published in scientific journal addiction People with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar drugs to treat diabetes or...
A Cleveland Clinic study identified key factors that may affect long-term weight loss in obese patients prescribed injectable semaglutide or liraglutide for the treatment of type...
study: Disproportionality analysis from World Health Organization data on semaglutide, liraglutide and suicidalityImage credit: myskin / Shutterstock.com In a recently published study, JAMA Network OpenResearchers are...
A recent review published in the journal cell, Researchers have collected and elucidated recent studies and clinical trials that highlight the mechanistic basis and beneficial outcomes...
A recent study published in the journal Communication Medicine, US researchers used large-scale language models (LLMs) to analyse over 391,000 unique discussions about glucagon-like peptide-1 (GLP-1)...
Recent Comments